Package Leaflet: Information for the User
Rivaroxaban Dr. Reddys 2.5 mg Film-Coated Tablets EFG
rivaroxaban
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
You have been prescribed Rivaroxaban Dr. Reddys because
or
Rivaroxaban Dr. Reddys contains the active substance rivaroxaban, which belongs to a group of medicines called antithrombotic medicines. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Dr. Reddys
Do not take Rivaroxaban Dr. Reddys and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take rivaroxaban.
Rivaroxaban Dr. Reddys should not be used in combination with other medicines that reduce blood clotting, other than aspirin or clopidogrel/ticlopidine, such as prasugrel or ticagrelor.
Be careful with Rivaroxaban Dr. Reddys
Tell your doctor if you have any of these situationsbefore taking Rivaroxaban Dr. Reddys. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If you need surgery
Children and adolescents
Rivaroxaban 2.5 mg is not recommended in children and adolescents under 18 years of age.There is not enough information on its use in children and adolescents.
Other medicines and Rivaroxaban Dr. Reddys
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, including those obtained without a prescription.
If any of the above circumstances apply to you, tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be increased. Your doctor will decide if you should be treated with this medicine and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend that you also use a preventive treatment.
If any of the above circumstances apply to you, tell your doctorbefore taking rivaroxaban, as the effect of rivaroxaban may be reduced. Your doctor will decide if you should be treated with rivaroxaban and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take rivaroxaban if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking rivaroxaban. If you become pregnant while taking rivaroxaban, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban may cause dizziness (a common side effect) or fainting (an uncommon side effect) (see section 4, "Possible side effects"). Do not drive or ride a bicycle or use tools or machines if you are affected by these symptoms.
Rivaroxaban Dr. Reddys contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e. it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
What dose to take
The recommended dose is one 2.5 mg tablet twice a day. Take rivaroxaban approximately at the same time every day (e.g. one tablet in the morning and one in the evening). This medicine can be taken with or without food.
If you have difficulty swallowing the whole tablet, talk to your doctor about other ways to take rivaroxaban. The tablet can be crushed and mixed with water or apple sauce immediately before taking it.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
You will not be given rivaroxaban alone. Your doctor will also tell you to take aspirin. If you are given rivaroxaban after an acute coronary syndrome, your doctor may tell you to take clopidogrel or ticlopidine as well.
If you receive rivaroxaban after a procedure to open a narrowed or blocked artery in your leg to restore blood flow, your doctor may also prescribe clopidogrel for you to take in addition to aspirin for a short period of time.
Your doctor will tell you the dose you should take (usually between 75 and 100 mg of aspirin per day or a daily dose of 75 to 100 mg of aspirin plus a daily dose of 75 mg of clopidogrel or a standard daily dose of ticlopidine).
When to start treatment with Rivaroxaban Dr. Reddys
Treatment with rivaroxaban after an acute coronary syndrome should be started as soon as possible after stabilization of the acute coronary syndrome, i.e. from 24 hours after hospital admission and at the time when parenteral anticoagulation therapy (by injection) would normally be discontinued.
Your doctor will tell you when to start treatment with Rivaroxaban Dr. Reddys if you have been diagnosed with coronary artery disease or peripheral artery disease.
Your doctor will decide how long you should continue treatment.
If you take more Rivaroxaban Dr. Reddys than you should
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
If you forget to take Rivaroxaban Dr. Reddys
If you forget to take a dose, take it as soon as you remember. Take the next tablet the next day and, after that, take one tablet every day, as usual.
Do not take a double dose to make up for forgotten doses.
If you stop taking Rivaroxaban Dr. Reddys
Do not stop taking rivaroxaban without talking to your doctor first, because rivaroxaban prevents the development of a serious condition.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine may cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation, rivaroxaban may cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Inform your doctor immediatelyif you experience any of the following symptoms:
Signs of bleeding:
A serious medical emergency. Seek medical attention immediately!)
Your doctor will decide whether to keep you under closer observation or change your treatment.
Signs of severe skin reaction:
Signs of severe allergic reaction:
These serious adverse effects are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 patients) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 patients).
General list of possible adverse effects
Frequent(may affect up to 1 in 10 patients)
Uncommon(may affect up to 1 in 100 patients)
Rare(may affect up to 1 in 1,000 patients)
Frequency not known(frequency cannot be estimated from available data)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for human use medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on each blister or vial after "CAD" or "EXP". The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Rivaroxaban Dr. Reddys
Core of the tablet: microcrystalline cellulose, lactose monohydrate, sodium croscarmellose, hypromellose, sodium lauryl sulfate, magnesium stearate. See section 2 "Rivaroxaban Dr. Reddys contains lactose and sodium"
Coating of the tablet: macrogol, hypromellose, titanium dioxide (E 171), yellow iron oxide (E 172).
The film-coated tablets of Rivaroxaban Dr. Reddys 2.5 mg are pale yellow, round, biconvex (approximately 6 mm in diameter) and have a "2.5" engraved on one side.
They are packaged in blisters, in boxes of 10, 14, 28, 30, 56, 98, 100, or 196 film-coated tablets
Only some package sizes may be marketed.
Reddy Pharma Iberia, S.A.
Avda. Josep Tarradellas nº 38
08029 Barcelona (Spain)
Phone number: 93.355.49.16
Fax number: 93.355.49.61
Manufacturer
betapharm Arzneimittel GmbH
Kobelweg 95
86156 Augsburg
Germany
Germany: | Rivaroxaban beta 2.5 mg film-coated tablets | betapharm Arzneimittel GmbH |
Spain: | Rivaroxaban Dr. Reddys 2.5 mg film-coated tablets EFG | Reddy Pharma Iberia, S.A. |
United Kingdom: | Rivaroxaban Dr. Reddy’s 2.5 mg Film- Coated Tablets | Dr. Reddy’s Laboratories (UK) Ltd. |
Italy: | RIVAROXABAN DR. REDDY’S 2.5 mg film-coated tablets | Dr. Reddy’s S.r.l. Italy |
France: | RIVAROXABAN REDDY PHARMA 2.5 mg, film-coated tablet | Reddy Pharma SAS France |
Date of the last revision of this prospectus:April 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)